Green Car Congress
About GCC Contact Add to My Yahoo!

« Ricardo Signs Framework Agreement with China’s Sinotruk | Main | Singapore’s First Public CNG Station to be Ready by Jan 2008; 4 More Planned »

Delhi Transit to Purchase 2,300 CNG and Diesel Buses by September

12 July 2007

Hindustan Times. The Delhi (India) Transport Corporation (DTC) will purchase 2,300 CNG and diesel buses to augment its fleet by September.

Out of the 2,300 low-floor buses, 2,000 will be CNG-powered while the rest will be diesel. The new fleet will also include 85 air-conditioned buses.

The DTC’s plans to purchase the new buses comes amid a crackdown on Blueline buses in the wake of a spate of accidents involving these private-run buses, dubbed as “killer buses” by the denizens.

The government of Delhi announced on 3 July that it was halting the privately operated Blueline bus service after a crashing bus hit five cars and killed a teenager. Delhi Chief Minister Shiela Dikshit said the service will be phased out in two years.

There have been 488 fatal accidents involving buses in three years and most of them belong to the Blueline service.

July 12, 2007 in Brief | Permalink | Comments (0) | TrackBack (0)

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/t/trackback/22062/20006734

Listed below are links to weblogs that reference Delhi Transit to Purchase 2,300 CNG and Diesel Buses by September:

Comments

Post a comment
[Please keep comments on topic. Disagreement is fine, insults, abuse or wild diversions are not. Comments not meeting those standards will be deleted. Abuse of another commenter’s email address will result in the banning of the offender from this site. In an attempt to prevent the posting of insulting and abusive comments, this site maintains a list of prohibited words and phrases, which, unfortunately, grows with time. Including one of the prohibited words or phrases will flag the comment as "spam", and it will be blocked.]






Green Car Congress © 2008 BioAge Group, LLC. All Rights Reserved. | Home | BioAge Group